[HTML][HTML] Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - nature.com
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

[PDF][PDF] Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck, CML Loeffler… - researchgate.net
Male breast cancer (MBC) is a rare condition that accounts for approximately 1% of all
breast cancer cases worldwide 1, 2. Its clinical management generally follows established …

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck… - Breast …, 2023 - abdn.elsevierpure.com
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck… - NPJ breast …, 2023 - pubmed.ncbi.nlm.nih.gov
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

[PDF][PDF] Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck… - Breast …, 2023 - aura.abdn.ac.uk
Male breast cancer (MBC) is a rare condition that accounts for approximately 1% of all
breast cancer cases worldwide 1, 2. Its clinical management generally follows established …

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - search.proquest.com
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.

S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - europepmc.org
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

[HTML][HTML] Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer

S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - ncbi.nlm.nih.gov
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.

S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - search.ebscohost.com
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.

S Chatterji, JM Niehues, M van Treeck… - NPJ Breast …, 2023 - europepmc.org
Breast cancer prognosis and management for both men and women are reliant upon
estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform …